Past Study

CAPE: Interventional Registry – Humira (Adalimumab) – Active Crohn’s Disease

Principal Investigator: Dr. Wael El-Matary

This research is to study long term safety information of Humira®, a treatment of Crohn’s Disease in children. This will help healthcare providers make sure children with Crohn’s get the best treatment possible.